HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Singh Selected Research

n-dodecane

11/2004Assessment of skin irritation and molecular responses in rat skin exposed to nonane, dodecane and tetradecane.
9/2004Percutaneous absorption and skin irritation upon low-level prolonged dermal exposure to nonane, dodecane and tetradecane in hairless rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Singh Research Topics

Disease

21Infections
01/2022 - 01/2000
17Neoplasms (Cancer)
01/2022 - 04/2000
15Tuberculosis (Tuberculoses)
01/2022 - 02/2000
7Body Weight (Weight, Body)
01/2019 - 04/2000
6Myocardial Infarction
01/2007 - 10/2000
5Pre-Eclampsia (Preeclampsia)
01/2022 - 06/2017
5Wounds and Injuries (Trauma)
03/2012 - 04/2002
5Ischemia
11/2007 - 10/2000
5Erythema
12/2005 - 03/2001
4Pain (Aches)
11/2021 - 06/2000
4Breast Neoplasms (Breast Cancer)
02/2021 - 01/2014
4Leprosy (Hansen's Disease)
07/2016 - 04/2007
4Stroke (Strokes)
02/2016 - 11/2000
4Inflammation (Inflammations)
08/2014 - 05/2004
4Cystic Fibrosis (Mucoviscidosis)
05/2010 - 01/2000
4Necrosis
08/2009 - 08/2004
4Infarction (Infarctions)
11/2007 - 10/2000
4Common Cold
07/2006 - 01/2000
3Lung Neoplasms (Lung Cancer)
02/2021 - 03/2005
3Atherosclerosis
01/2020 - 07/2004
3Leukemia
01/2019 - 07/2001
3Psoriasis (Pustulosis Palmaris et Plantaris)
04/2018 - 01/2001
3Blister (Bulla)
04/2016 - 05/2006
3Alzheimer Disease (Alzheimer's Disease)
02/2016 - 04/2001
3Hypertension (High Blood Pressure)
01/2016 - 06/2000
3Thrombosis (Thrombus)
04/2015 - 09/2001
3Latent Tuberculosis
01/2015 - 02/2008
3Coronary Disease (Coronary Heart Disease)
03/2008 - 04/2001
3Hyperglycemia
01/2008 - 07/2002
3Pulmonary Tuberculosis
04/2007 - 10/2000
3Eosinophilia
05/2005 - 02/2001
3Pulmonary Eosinophilia (Eosinophilic Pneumonia)
05/2005 - 02/2001
3Brain Ischemia (Cerebral Ischemia)
02/2005 - 09/2000
2Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 08/2015
2Mouth Neoplasms (Oral Cancer)
01/2021 - 09/2003
2Ischemic Stroke
01/2020 - 02/2001
2Birth Weight (Birth Weights)
01/2018 - 01/2000
2Vitiligo
12/2017 - 11/2014
2Fibrosis (Cirrhosis)
10/2017 - 04/2012
2Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 05/2001
2Hypoxia (Hypoxemia)
01/2017 - 11/2010
2Bovine Tuberculosis
10/2016 - 05/2000
2Cataract (Cataracts)
04/2016 - 07/2011
2Dementia (Dementias)
02/2016 - 01/2016
2Brain Diseases (Brain Disorder)
02/2016 - 01/2016
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2016 - 08/2014

Drug/Important Bio-Agent (IBA)

14AntigensIBA
01/2022 - 05/2000
13Proteins (Proteins, Gene)FDA Link
02/2014 - 03/2000
9CytokinesIBA
08/2009 - 05/2000
9AntibodiesIBA
05/2005 - 11/2000
8Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2015 - 03/2000
7Interferon-gamma (Interferon, gamma)IBA
01/2022 - 05/2000
7Biomarkers (Surrogate Marker)IBA
06/2018 - 11/2004
6Estrogens (Estrogen)FDA Link
01/2017 - 06/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2008 - 08/2004
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 11/2005
5DNA (Deoxyribonucleic Acid)IBA
11/2016 - 01/2001
5Immunoglobulin G (IgG)IBA
09/2014 - 02/2001
5Tuberculin (PPD)IBA
02/2014 - 05/2000
5SteamIBA
07/2006 - 01/2000
5Peptides (Polypeptides)IBA
03/2006 - 03/2000
4Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 01/2000
4Hormones (Hormone)IBA
04/2018 - 01/2014
4EnzymesIBA
12/2017 - 11/2000
4VaccinesIBA
11/2014 - 07/2000
4Interleukin-12 (IL 12)IBA
08/2009 - 07/2000
4Immunoglobulin A (IgA)IBA
08/2009 - 11/2001
4Biological ProductsIBA
01/2008 - 10/2000
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 10/2007
3AntioxidantsIBA
02/2016 - 06/2006
3Saline SolutionIBA
01/2016 - 11/2004
3CholesterolIBA
12/2014 - 01/2004
3ElementsIBA
11/2014 - 03/2009
3Pharmaceutical PreparationsIBA
04/2014 - 02/2000
3RNA (Ribonucleic Acid)IBA
04/2013 - 10/2000
3LipidsIBA
03/2008 - 10/2007
3Creatine Kinase (Creatine Phosphokinase)IBA
11/2007 - 10/2000
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2007 - 10/2000
3AcidsIBA
10/2007 - 10/2000
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2006 - 09/2003
3Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
05/2005 - 02/2001
3nonaneIBA
11/2004 - 03/2001
2C-Reactive ProteinIBA
01/2020 - 07/2000
2ORALIT (ORS)IBA
01/2020 - 01/2006
2Amino AcidsFDA Link
04/2018 - 08/2004
2CatalaseIBA
12/2017 - 06/2006
2Messenger RNA (mRNA)IBA
12/2017 - 09/2004
2Angiotensin IIIBA
10/2017 - 10/2000
2IntegrinsIBA
10/2017 - 09/2006
2SteroidsIBA
01/2017 - 02/2005
2Ethanol (Ethyl Alcohol)IBA
07/2016 - 06/2006
2Gonadal HormonesIBA
02/2016 - 04/2001
2Cholinergic Agents (Cholinergics)IBA
02/2016 - 01/2016
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2016 - 08/2007

Therapy/Procedure

23Therapeutics
06/2018 - 01/2001
6Drug Therapy (Chemotherapy)
04/2018 - 02/2000
4Radiotherapy
01/2022 - 04/2000
4Percutaneous Coronary Intervention
11/2001 - 09/2000
3Ligation
01/2016 - 03/2001
2Vitrectomy
01/2020 - 06/2007